Notice Number: NOT-CA-20-030
Release Date: February 21, 2020
First Available Due Date:May 15, 2020
Expiration Date:May 16, 2020
NATIONAL CANCER INSTITUTE (NCI)
This Notice of Special Interest informs current awardees that the National Cancer Institute (NCI) is providing the opportunity for supplemental funding to facilitate collaboration, preparation, harmonization, pooling and analyses of data collected for steering committee approved scientific projects within the NCI Cohort Consortium. Through these administrative supplements, the NCI seeks to enhance the rapid completion of projects, data access, and data sharing.
This Notice also informs current NCI awardees that NCI intends to provide administrative supplements to investigators with at least one steering committee approved NCI Cohort Consortium project. Preference will be given to projects led by an early stage investigator (ESI), as well as those that address a research gap.
These supplements will achieve the following:
The mission of the NCI Cohort Consortium is to foster communication among investigators leading cohort studies of cancer, promote collaborative research projects for topics not easily addressed in a single study, and identify and address common challenges in cohort research. This supplement will promote research conducted through the NCI Cohort Consortium, provide momentum for the completion of ongoing research to advance the mission of the NCI Cohort Consortium. The bulk of the research in the NCI Cohort Consortium emanates from the steering committee approved projects and scientific working groups. Typically, these projects and working groups involve groups of scientists from multiple institutions who have agreed to pool data from their individual cohort studies for combined analyses, to address research questions that cannot be answered in a single study. The 48 steering-committee approved projects are in various stages of development, data aggregation, and analyses. The purpose of the supplements is to facilitate the completion of the studies which are often delayed due to lack of resources. In line with the NCI Cohort Consortium’s strategic plan (2018-2021), the supplements will enhance data aggregation, analysis, and data sharing. Successful applicants are required to share de-identified data derived from their projects and the harmonized datasets among consortium members through the NCI designated central data coordinating center. Successful applicants are also required to share their aggregate results, analysis parameters, harmonized phenotypes and variables through submission to NCI designated data repositories and/or dbGaP.
Application and Submission Information
Applications for this initiative must be submitted using the following opportunity or its subsequent reissued equivalent.
Budget and Period of Support:
Administrative Review Process:
NCI will conduct administrative reviews of applications submitted to their IC and will support the most meritorious applications submitted for consideration, based upon the availability of funds.
Applicants are strongly encouraged to notify the program contact at the Institute supporting the parent award that a request has been submitted in response to this NOSI to facilitate efficient processing of the application.
Applications nonresponsive to the terms and conditions will be not be considered for this NOSI initiative.
Please direct all inquiries to:
Nonye Harvey, DrPH, MPH
Division of Cancer Control and Population Sciences
National Cancer Institute (NCI)